Denis Chem Lab

Who are the top shareholders of the Denis Chem Lab?

The top shareholders of Denis Chem Lab are Anar Himanshu Patel with 21.7%, V-s Holding B.v. at 20.74%, and individual investors holding a combined 27.41%. There are no institutional or pledged promoter holdings reported.

The top shareholders of Denis Chem Lab include Anar Himanshu Patel, who holds the largest share at 21.7%. Following him is V-s Holding B.v., with a stake of 20.74%. Additionally, individual investors collectively hold 27.41% of the company's shares. There are no institutional holdings or pledged promoter holdings reported.

Who are in the management team of Denis Chem Lab?

As of March 2023, the management team of Denis Chem Lab includes Dinesh B Patel (Chairman), Himanshu C Patel (Managing Director), Gaurang Dalal, Anar H Patel, Gauri Trivedi, and Hemendrakumar C Shah (all Independent Non-Executive Directors).

As of March 2023, the management team of Denis Chem Lab includes the following individuals:<BR><BR>1. Dinesh B Patel - Chairman & Non Executive Director<BR>2. Himanshu C Patel - Executive Director / Managing Director / Promoter<BR>3. Gaurang Dalal - Independent Non Executive Director<BR>4. Anar H Patel - Non Executive Director<BR>5. Gauri Trivedi - Independent Non Executive Director<BR>6. Hemendrakumar C Shah - Independent Non Executive Director<BR><BR>These members play various roles within the company's governance structure.

What does Denis Chem Lab do?

Denis Chem Lab Ltd manufactures sterile intravenous injectables and IV fluids, operating in the Pharmaceuticals & Biotechnology industry. As of March 2025, it reported net sales of 41 Cr and a net profit of 1 Cr, with a market cap of Rs 145 Cr.

Overview: <BR>Denis Chem Lab Ltd is a company engaged in the manufacturing of sterile intravenous (IV) injectables and IV fluids, operating within the Pharmaceuticals & Biotechnology industry and classified as a Micro Cap.<BR><BR>History: <BR>Denis Chem Lab Ltd was incorporated in 1980 and became a Public Limited Company in 1982. The company started commercial production of sterile IV injectables in 1984 and ventured into manufacturing IV fluids in PP bottles using BFS technology in 1995. The latest reported quarter for net sales and profit is March 2025.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 41 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 1 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: Rs 145 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 18.00 <BR>Industry P/E: 41 <BR>Dividend Yield: 2.37% <BR>Debt-Equity: -0.29 <BR>Return on Equity: 9.80% <BR>Price to Book: 1.78<BR><BR>Contact Details: <BR>Address: Block No 457 Kalol Taluka, Chhatral Gandhinagar Gujarat : 382729 <BR>Tel: 91-2764-233596/233613 <BR>Email: denishchem401@gmail.com <BR>Website: http://www.denischemlab.com

Has Denis Chem Lab declared dividend?

Yes, Denis Chem Lab Ltd has declared a 25% dividend, amounting to 2.5 per share, with an ex-date of September 19, 2024. While recent returns have been negative, the company has shown significant growth over the longer term, particularly with a total return of 234.06% over the past five years.

Denis Chem Lab Ltd has declared a 25% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 25%<BR>- Amount per share: 2.5<BR>- Ex-date: 19 Sep 24<BR><BR>Dividend Yield: 2.37%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -36.1%, the dividend return was 0%, resulting in a total return of -36.1%.<BR><BR>Over the past year, the price return was -37.61%, the dividend return was 1.39%, leading to a total return of -36.22%.<BR><BR>In the 2-year period, the price return was 35.7%, the dividend return was 4.70%, which resulted in a total return of 40.4%.<BR><BR>For the last 3 years, the price return was 86.63%, the dividend return was 11.78%, culminating in a total return of 98.41%.<BR><BR>Over the past 4 years, the price return was 59.07%, the dividend return was 12.70%, resulting in a total return of 71.77%.<BR><BR>In the 5-year period, the price return was 213.91%, the dividend return was 20.15%, leading to a total return of 234.06%.<BR><BR>Overall, Denis Chem Lab Ltd has declared a dividend, and while recent returns have been negative in the shorter term, the longer-term returns show significant growth, particularly in the 5-year period.

Who are the peers of the Denis Chem Lab?

Peers of Denis Chem Lab include Sun Pharma, Divi's Lab, Cipla, Torrent Pharma, Dr Reddy's Labs, BDH Industries, Tyche Industries, Quest, and Sotac Pharma. Denis Chem Lab has average management risk, below-average growth, and the lowest 1-year return among its peers at -38.43%.

Peers: The peers of Denis Chem Lab are Sun Pharma.Inds., Divi's Lab., Cipla, Torrent Pharma, Dr Reddy's Labs, BDH Industries, Tyche Industries, Quest, and Sotac Pharma.<BR><BR>Quality Snapshot: Excellent management risk is observed at Sun Pharma.Inds., Divi's Lab., Cipla, Torrent Pharma, Dr Reddy's Labs, BDH Industries, and Tyche Industries, while Average management risk is found at Denis Chem Lab. Below Average management risk is noted at Sotac Pharma and Vaishali Pharma. Growth is Excellent for Sun Pharma.Inds., Cipla, and Dr Reddy's Labs, while Below Average growth is seen at Divi's Lab., Torrent Pharma, Denis Chem Lab, BDH Industries, Tyche Industries, and Vaishali Pharma. Excellent capital structure is present at Sun Pharma.Inds., Divi's Lab., Cipla, Dr Reddy's Labs, BDH Industries, and Tyche Industries, while Good capital structure is noted at Torrent Pharma and Quest, and Average capital structure is found at Sotac Pharma.<BR><BR>Return Snapshot: Divi's Lab. has the highest 1-year return at 51.69%, while Denis Chem Lab has the lowest at -38.43%. This indicates that Denis Chem Lab's return is significantly lower than its peers. Additionally, BDH Industries, Tyche Industries, and Denis Chem Lab have negative six-month returns.

What is the technical trend for Denis Chem Lab?

As of April 30, 2025, Denis Chem Lab's trend is mildly bearish, influenced by daily moving averages and weekly Bollinger Bands, though the weekly MACD is mildly bullish and the monthly RSI is bullish, indicating mixed momentum and a weak bearish sentiment with potential for recovery.

As of 30 April 2025, the technical trend for Denis Chem Lab has changed from bearish to mildly bearish. The current stance is mildly bearish, primarily driven by the daily moving averages indicating a bearish trend and the weekly Bollinger Bands also showing bearish signals. The MACD on a weekly basis is mildly bullish, providing some counterbalance, while the monthly MACD remains mildly bearish. The RSI on a monthly basis is bullish, but with no signal on the weekly, indicating mixed momentum. Overall, the indicators suggest a weak bearish sentiment with some signs of potential recovery in the longer term.

How big is Denis Chem Lab?

As of 24th July, Denis Chem Lab Ltd has a market capitalization of 139.00 Cr, with recent Net Sales of 173.30 Cr and a Net Profit of 8.08 Cr. The company's Shareholder's Funds are 80.37 Cr and Total Assets amount to 109.35 Cr.

As of 24th July, Denis Chem Lab Ltd has a market capitalization of 139.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 173.30 Cr and a Net Profit of 8.08 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, with Shareholder's Funds amounting to 80.37 Cr and Total Assets of 109.35 Cr.

How has been the historical performance of Denis Chem Lab?

Denis Chem Lab has shown steady growth in net sales and profitability, with net sales increasing from 124.12 Cr in Mar'19 to 173.30 Cr in Mar'25, and profit after tax rising from 6.35 Cr to 8.08 Cr during the same period. The company has also improved its financial stability, reducing total debt significantly while maintaining positive cash flow.

Answer:<BR>The historical performance of Denis Chem Lab shows a steady growth in net sales and profitability over the years.<BR><BR>Breakdown:<BR>Denis Chem Lab's net sales have increased from 124.12 Cr in Mar'19 to 173.30 Cr in Mar'25, reflecting a consistent upward trend. Total operating income has followed a similar trajectory, rising from 124.12 Cr in Mar'19 to 173.30 Cr in Mar'25. However, total expenditure has also increased, from 110.26 Cr in Mar'19 to 157.19 Cr in Mar'25, which has impacted operating profit, which peaked at 22.63 Cr in Mar'24 before declining to 18.48 Cr in Mar'25. Profit before tax has shown improvement from 5.92 Cr in Mar'19 to 11.11 Cr in Mar'25, while profit after tax has increased from 6.35 Cr in Mar'19 to 8.08 Cr in Mar'25. The company's total assets have grown from 97.42 Cr in Mar'20 to 112.27 Cr in Mar'25, alongside a decrease in total debt from 10.51 Cr in Mar'20 to 0.82 Cr in Mar'25, indicating improved financial stability. Cash flow from operating activities has fluctuated but remained positive, with a notable cash flow of 12.00 Cr in Mar'25. Overall, Denis Chem Lab has demonstrated a robust growth trajectory in sales and profitability, alongside a strengthening balance sheet.

Is Denis Chem Lab overvalued or undervalued?

As of November 17, 2025, Denis Chem Lab is considered undervalued with a PE ratio of 16.73 and favorable valuation metrics compared to its industry peers, despite a recent stock underperformance of -47.04% against the Sensex.

As of 17 November 2025, Denis Chem Lab's valuation grade has moved from very attractive to attractive, indicating a shift in market perception. The company is currently assessed as undervalued, given its PE ratio of 16.73, EV to EBIT of 8.73, and a Price to Book Value of 1.36. These metrics suggest that the company is trading at a reasonable valuation compared to its peers.<BR><BR>In comparison to its industry, Denis Chem Lab's PE ratio is significantly lower than that of Supreme Industries and Astral, which are both categorized as very expensive with PE ratios of 54.4 and 77.37, respectively. Additionally, the company's EV to EBITDA ratio of 5.94 is more favorable than the industry average, reinforcing its undervaluation status. While the stock has underperformed against the Sensex over the past year, with a return of -47.04% compared to the Sensex's 9.50%, the current valuation metrics suggest that there is potential for recovery and growth moving forward.

When is the next results date for Denis Chem Lab Ltd?

The next results date for Denis Chem Lab Ltd is 14 February 2026.

The next results date for Denis Chem Lab Ltd is scheduled for 14 February 2026.

Are Denis Chem Lab Ltd latest results good or bad?

Denis Chem Lab Ltd's latest results are concerning, showing a 3.45% year-on-year revenue decline and a 37.39% drop in net profit, indicating significant operational challenges and deteriorating financial performance. Overall, these results are considered bad for the company.

Denis Chem Lab Ltd's latest results indicate a concerning trend. In the second quarter of FY26, the company reported a revenue decline of 3.45% year-on-year, totaling ₹46.17 crores, despite a slight sequential improvement of 6.68%. More troubling is the significant contraction in operating margins, which fell to 9.23% from 12.30% in the same quarter last year, reflecting increasing cost pressures.<BR><BR>Net profit also took a hit, dropping by 37.39% year-on-year to ₹2.21 crores, and it declined 10.89% from the previous quarter. This suggests that even with a slight increase in revenue, the company's profitability is under severe strain.<BR><BR>Overall, the results paint a negative picture, highlighting operational challenges and deteriorating financial performance. The stock has underperformed significantly compared to the broader market and the pharmaceutical sector, leading to a loss of investor confidence. Given these factors, the latest results can be considered bad for Denis Chem Lab Ltd.

Should I buy, sell or hold Denis Chem Lab Ltd?

Why is Denis Chem Lab Ltd falling/rising?

As of 11-Mar, Denis Chem Lab Ltd's stock price is at Rs 72.74, showing a short-term increase but underperforming compared to its sector and facing declining investor interest. The stock is also trading below key moving averages and is 3.7% above its 52-week low.

As of 11-Mar, Denis Chem Lab Ltd's stock price is rising, currently at Rs 72.74, reflecting an increase of Rs 0.56 or 0.78%. This rise follows a two-day consecutive gain, during which the stock has returned 2.38%. Despite this recent uptick, the stock has been underperforming compared to its sector, with a performance that is 1.49% lower than the sector average. <BR><BR>Additionally, the stock is currently trading 3.7% away from its 52-week low of Rs 70.05 and is below all key moving averages, indicating a generally weak trend. Over the past week, the stock has declined by 2.52%, although it has outperformed the Sensex, which fell by 2.85% during the same period. <BR><BR>Investor participation has notably decreased, with delivery volume dropping by 70.48% compared to the five-day average, suggesting a lack of strong buying interest. Overall, while the stock is experiencing a short-term rise, the broader context indicates ongoing challenges, including underperformance relative to the sector and declining investor engagement.

Why is Denis Chem Lab Ltd falling/rising?

As of 12-Mar, Denis Chem Lab Ltd's stock price is currently rising at 72.36, despite a recent decline over the past week and month. The stock is underperforming its moving averages and is close to its 52-week low, suggesting ongoing challenges despite today's positive momentum.

As of 12-Mar, Denis Chem Lab Ltd's stock price is rising, currently at 72.36, with a change of 0.66 (0.92%) upward. This increase comes despite the stock's recent performance, which shows a decline of 1.07% over the past week and 6.29% over the past month. However, it is noteworthy that the stock has outperformed its sector by 1.75% today, indicating some positive momentum relative to its peers.<BR><BR>Despite the current rise, the stock is still trading below its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which suggests a longer-term downward trend. Additionally, investor participation has decreased, with delivery volume falling by 16.21% compared to the 5-day average, indicating reduced interest from investors.<BR><BR>The stock is also close to its 52-week low, being only 3.19% away from the low of Rs 70.05. This proximity to a low point may contribute to some buying interest, as investors might see it as a potential opportunity. Overall, while the stock is experiencing a rise today, the broader context indicates ongoing challenges in its performance.

Which are the latest news on Denis Chem Lab?